 1. Studies showed these patients have weak immune against MM due to the immune checkpoint mediated by the PD1PD-L1 interaction between immune cells and MM. Anti-PD-1 antibody anti-PD1 disrupts this interaction, thus unleashing immune cell function and leading to killing of MM cells. 